R. Douglas Bruce

6.2k total citations · 1 hit paper
133 papers, 4.7k citations indexed

About

R. Douglas Bruce is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, R. Douglas Bruce has authored 133 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Epidemiology, 47 papers in Infectious Diseases and 25 papers in Public Health, Environmental and Occupational Health. Recurrent topics in R. Douglas Bruce's work include HIV, Drug Use, Sexual Risk (43 papers), HIV/AIDS Research and Interventions (35 papers) and Opioid Use Disorder Treatment (25 papers). R. Douglas Bruce is often cited by papers focused on HIV, Drug Use, Sexual Risk (43 papers), HIV/AIDS Research and Interventions (35 papers) and Opioid Use Disorder Treatment (25 papers). R. Douglas Bruce collaborates with scholars based in United States, Tanzania and Malaysia. R. Douglas Bruce's co-authors include Frederick L. Altice, Marc Froissart, Jérôme Rossert, Frederick Van Lente, Christopher H. Schmid, Lesley A. Stevens, Josef Coresh, Tom Greene, John W. Kusek and Andrew S. Levey and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

R. Douglas Bruce

127 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKD

2008 811 citations Lesley A. Stevens, Josef Coresh et al. American Journal of Kidney Diseases profile →

Peers

R. Douglas Bruce

EPIDE

PHEOH

NEPHR

PPCH

Thomas K. Welty United States

Fabrice Bonnet France

Ashish Bhalla India

Bruno Mégarbane France

Yu‐Shan Huang Taiwan

Thomas R. Ziegler United States

Thu Anh Nguyen Vietnam

Robert L. Danner United States

Kuo‐Chin Huang Taiwan

John P. Forman United States

Thomas K. Welty United States

R. Douglas Bruce

2.0k ×1.1

EPIDE

525 ×0.4

1.1k ×1.2

PHEOH

364 ×0.6

NEPHR

725 ×1.5

PPCH

Citations per year, relative to R. Douglas Bruce R. Douglas Bruce (= 1×) peers Thomas K. Welty

Countries citing papers authored by R. Douglas Bruce

Since Specialization

Citations

This map shows the geographic impact of R. Douglas Bruce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Douglas Bruce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Douglas Bruce more than expected).

Fields of papers citing papers by R. Douglas Bruce

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Douglas Bruce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Douglas Bruce. The network helps show where R. Douglas Bruce may publish in the future.

Co-authorship network of co-authors of R. Douglas Bruce

This figure shows the co-authorship network connecting the top 25 collaborators of R. Douglas Bruce. A scholar is included among the top collaborators of R. Douglas Bruce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Douglas Bruce. R. Douglas Bruce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jones, A. Daniel, Hongmei Zhang, Su Chen, et al.. (2023). Polymorphisms in Glutathione S-Transferase (GST) Genes Modify the Effect of Exposure to Maternal Smoking Metabolites in Pregnancy and Offspring DNA Methylation. Genes. 14(8). 1644–1644.

Minja, Lilian Tina, Jerry Hella, Jessie Mbwambo, et al.. (2021). High burden of tuberculosis infection and disease among people receiving medication-assisted treatment for substance use disorder in Tanzania. PLoS ONE. 16(4). e0250038–e0250038. 9 indexed citations

Kresina, Thomas F., et al.. (2018). Integration of viral hepatitis services into opioid treatment programs. Journal of Opioid Management. 4(6). 369–381. 1 indexed citations

Springer, Sandra A. & R. Douglas Bruce. (2018). A pilot survey of attitudes and knowledge about opioid substitution therapy for HIV-infected prisoners. Journal of Opioid Management. 4(2). 81–86. 11 indexed citations

Hulskotte, Ellen G. J., R. Douglas Bruce, Hwa-ping Feng, et al.. (2015). Pharmacokinetic interaction between HCV protease inhibitor boceprevir and methadone or buprenorphine in subjects on stable maintenance therapy. European Journal of Clinical Pharmacology. 71(3). 303–311. 13 indexed citations

Lambdin, Barrot H., et al.. (2013). Identifying Programmatic Gaps: Inequities in Harm Reduction Service Utilization among Male and Female Drug Users in Dar es Salaam, Tanzania. PLoS ONE. 8(6). e67062–e67062. 54 indexed citations

Bruce, R. Douglas, Barrot H. Lambdin, Jessie Mbwambo, et al.. (2013). Lessons from Tanzania on the integration of HIV and tuberculosis treatments into methadone assisted treatment. International Journal of Drug Policy. 25(1). 22–25. 23 indexed citations

Bruce, R. Douglas, et al.. (2013). Pharmacokinetic Interactions between Buprenorphine/Naloxone and Raltegravir in Subjects Receiving Chronic Buprenorphine/Naloxone Treatment. The American Journal of Drug and Alcohol Abuse. 39(2). 80–85. 5 indexed citations

Vourvahis, Manoli, Rong Wang, Daniel Gruener, et al.. (2012). Effect of lersivirine co-administration on pharmacokinetics of methadone in healthy volunteers. Drug and Alcohol Dependence. 126(1-2). 183–188. 8 indexed citations

10.

Schwarz, Ryan, Alexei Zelenev, R. Douglas Bruce, & Frederick L. Altice. (2012). Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence. Journal of Substance Abuse Treatment. 43(4). 451–457. 56 indexed citations

11.

Bruce, R. Douglas, et al.. (2011). Pharmacokinetic drug interactions and adverse consequences between psychotropic medications and pharmacotherapy for the treatment of opioid dependence. The American Journal of Drug and Alcohol Abuse. 37(1). 1–11. 27 indexed citations

12.

Bruce, R. Douglas, Frederick L. Altice, David E. Moody, et al.. (2010). Pharmacokinetic Interactions Between Buprenorphine/Naloxone and Once-Daily Lopinavir/Ritonavir. JAIDS Journal of Acquired Immune Deficiency Syndromes. 54(5). 511–514. 14 indexed citations

13.

Hudelson, Sarah E., Natalia Marlowe, Wei Huang, et al.. (2009). Analysis of HIV Type 1 gp41 and Enfuvirtide Susceptibility among Men in the United States Who Were HIV Infected Prior to Availability of HIV Entry Inhibitors. AIDS Research and Human Retroviruses. 25(7). 701–705. 5 indexed citations

14.

Stevens, Lesley A., Josef Coresh, Christopher H. Schmid, et al.. (2008). Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKD. American Journal of Kidney Diseases. 51(3). 395–406. 811 indexed citations breakdown →

15.

Maru, Duncan, R. Douglas Bruce, Sanjay Basu, & Frederick L. Altice. (2008). Clinical Outcomes of Hepatitis C Treatment in a Prison Setting: Feasibility and Effectiveness for Challenging Treatment Populations. Clinical Infectious Diseases. 47(7). 952–961. 52 indexed citations

16.

Eshleman, Susan H., Sarah E. Hudelson, R. Douglas Bruce, et al.. (2007). Analysis of HIV Type 1 gp41 Sequences in Diverse HIV Type 1 Strains. AIDS Research and Human Retroviruses. 23(12). 1593–1598. 8 indexed citations

17.

Maru, Duncan, et al.. (2007). Initiation, Adherence, and Retention in a Randomized Controlled Trial of Directly Administered Antiretroviral Therapy. AIDS and Behavior. 12(2). 284–293. 33 indexed citations

18.

Bruce, R. Douglas, et al.. (1991). Comparison of the up-and-down method and the fixed-dose procedure for acute oral toxicity testing. Food and Chemical Toxicology. 29(4). 259–263. 10 indexed citations

19.

Bruce, R. Douglas, et al.. (1989). Subaru-Isuzu Assembly Plant Floors. ACI Concrete International. 11(6). 23–27. 1 indexed citations

20.

Bruce, R. Douglas. (1975). The rape of Sheila Robinson.. PubMed. 22(4). 32–3, 47. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact